Key result
In patients undergoing hip fracture surgery, the use of a cemented prosthesis significantly increased the risk of 3-year mortality compared to an uncemented prosthesis (HR 2.624).
Why the study?
What are the mortality rates and predisposing factors in patients operated for a hip fracture over a 3-year follow-up period?
Cohort (n=120)
No
What are the mortality rates and predisposing factors in patients operated for a hip fracture over a 3-year follow-up period?
Hazard Ratio: 2.624 (95% CI 1.192–5.777)
Absolute Event Rate: 46.7% vs 26.7%
p-value: p=0.017
In patients undergoing hip fracture surgery, high ASA scores, specific comorbidities (CHF, malignancy, neurodegenerative diseases), and the use of cemented prostheses are associated with significantly increased 3-year mortality.
No takes yet. Share an insight, caveat, or question.
Cemented prostheses were associated with higher 3-year mortality after hip fracture surgery; leaves open confounding and requires randomized confirmation.
Kılcı et al. (2016) conducted a cohort in Hip fracture (n=120). Cemented prosthesis vs. Uncemented prosthesis was evaluated on Mortality at 3 years (HR 2.624, 95% CI 1.192-5.777, p=0.017). In patients undergoing hip fracture surgery, the use of a cemented prosthesis significantly increased the risk of 3-year mortality compared to an uncemented prosthesis (HR 2.624).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: